Zentalis Pharmaceuticals, Inc. Share Price
NASDAQ: ZNTL | Small CapZentalis Pharmaceuticals, Inc. Stock Performance
Open $4.80 | Prev. Close $4.99 | Circuit Range N/A |
Day Range $4.07 - $4.80 | Year Range $1.22 - $6.94 | Volume 69,327 |
Average Traded $4.28 |
Zentalis Pharmaceuticals, Inc. Share Price Today
As of 10 August 2026, Zentalis Pharmaceuticals, Inc.'s share price is $4.22. The stock opened at $4.80, compared to its previous close of $4.99. During today's trading session, Zentalis Pharmaceuticals, Inc.'s share price traded between $4.07 and $4.80, with an average price of $4.44. Over the past 52 weeks, the stock has recorded a high of $6.94 and a low of $1.22. In terms of performance, Zentalis Pharmaceuticals, Inc.'s share price has risen by 76.57% over the last six months and is up 148.97% on a year-on-year basis.
Zentalis Pharmaceuticals, Inc. Share Price Chart
Zentalis Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators
Market Cap $303.29M | PE Ratio (TTM) -2.21 | Dividend Yield N/A |
EPS (TTM) $-1.91 | Revenue (TTM) N/A | Return On Equity (TTM) -63.39% |
Profit Margin N/A | Debt to Equity 0.17 | Quarterly Earnings Growth YoY 33.54% |
Zentalis Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
Zentalis Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. The company develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer and other tumor types. It also develops ZN-c3-001, a phase 1 study that evaluated azenosertib monotherapy in solid tumors; and MAMMOTH (ZN-c3-006) is a Phase 1/2 clinical trial of azenosertib in patients with PARP-inhibitor resistant ovarian cancer. It has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC. Zentalis Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Zentalis Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $4.66 | $4.21 | -11.19% |
Jul 2026 | $4.79 | $4.74 | -2.27% |
Jun 2026 | $3.99 | $4.84 | +21.12% |
May 2026 | $4.00 | $4.00 | -0.12% |
Apr 2026 | $2.43 | $4.00 | +70.43% |
Mar 2026 | $2.44 | $2.35 | -1.67% |
Feb 2026 | $2.42 | $2.39 | -2.05% |
Jan 2026 | $1.33 | $2.44 | +81.41% |
Dec 2025 | $1.39 | $1.34 | -5.94% |
Nov 2025 | $1.54 | $1.43 | -4.03% |
Oct 2025 | $1.56 | $1.49 | -1.97% |
Sep 2025 | $1.71 | $1.52 | -10.32% |
ZNTL Share Price FAQs
What is Zentalis Pharmaceuticals, Inc. share price today?
What is the 52 week high and 52 week low of Zentalis Pharmaceuticals, Inc. stock?
What is ZNTL's market capitalisation today?
What is ZNTL's net income for the last quarter?
What is the 5 year returns of ZNTL?
What is the high & low stock price of ZNTL today?
Can I buy ZNTL shares in India?